• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪细胞因子在尿毒症表型中的新兴多效作用。

The emerging pleiotrophic role of adipokines in the uremic phenotype.

机构信息

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Curr Opin Nephrol Hypertens. 2010 Jan;19(1):37-42. doi: 10.1097/MNH.0b013e328332fc2b.

DOI:10.1097/MNH.0b013e328332fc2b
PMID:19823084
Abstract

PURPOSE OF REVIEW

The obesity epidemic is undoubtedly increasing the total end-stage renal disease population, which has a larger proportion of obese individuals on reaching the dialysis stage. This review discusses recent advances in the pathophysiology of adipose tissue and adipokines that may contribute to increased risk of progression towards end-stage renal disease and cardiovascular damage.

RECENT FINDINGS

Although leptin effects on blood pressure may negatively affect kidney function, leptin may also induce vascular damage through central and direct effects on both vessels and heart. The contradictory results of adiponectin in uremia are possibly confounded by the disease circumstances. Visfatin may have previously unrecognized roles in angiogenesis and nutrient homeostasis. As visfatin is a ubiquitously expressed enzyme, it may be inaccurate to refer to it as an adipokine.

SUMMARY

We still face many unknowns when understanding the putative pleiotrophic effects that adipokines exert in the uremic milieu. Mechanistic and interventional studies are needed to move forward in this area. Conflicting results in patients with ESRD, in whom both beneficial and detrimental effects in uremia outcome are found, are perhaps the consequence of different timing or context-sensitive effects. Specifically, the presence of protein energy wasting and the changing pattern of disease risk may hinder or even reverse the natural action of these molecules.

摘要

目的综述

肥胖症的流行无疑增加了终末期肾病患者的总人数,这些患者在进入透析阶段时肥胖人群的比例更大。这篇综述讨论了脂肪组织和脂肪因子的病理生理学的最新进展,这些进展可能导致进展为终末期肾病和心血管损害的风险增加。

最近的发现

尽管瘦素对血压的影响可能对肾功能产生负面影响,但瘦素也可能通过对血管和心脏的中枢和直接作用引起血管损伤。尿毒症中脂联素的矛盾结果可能与疾病情况有关。内脂素在血管生成和营养稳态中可能具有以前未被认识到的作用。由于内脂素是一种广泛表达的酶,因此将其称为脂肪因子可能并不准确。

总结

在理解脂肪因子在尿毒症环境中可能发挥的多效性作用时,我们仍面临许多未知数。在这一领域需要进行机制和干预研究才能取得进展。在患有 ESRD 的患者中出现相互矛盾的结果,这些患者在尿毒症结果中既有有益作用也有有害作用,这可能是由于不同的时间或上下文敏感的作用。具体来说,蛋白质能量消耗的存在和疾病风险的变化模式可能会阻碍甚至逆转这些分子的自然作用。

相似文献

1
The emerging pleiotrophic role of adipokines in the uremic phenotype.脂肪细胞因子在尿毒症表型中的新兴多效作用。
Curr Opin Nephrol Hypertens. 2010 Jan;19(1):37-42. doi: 10.1097/MNH.0b013e328332fc2b.
2
Adipokines as uremic toxins.脂肪细胞因子作为尿毒症毒素。
J Ren Nutr. 2012 Jan;22(1):81-5. doi: 10.1053/j.jrn.2011.10.029.
3
Adipokines and the cardiovascular system: mechanisms mediating health and disease.脂肪细胞因子与心血管系统:介导健康与疾病的机制。
Can J Physiol Pharmacol. 2012 Aug;90(8):1029-59. doi: 10.1139/y2012-053. Epub 2012 May 30.
4
Obesity in chronic kidney disease: good or bad?慢性肾脏病中的肥胖:有益还是有害?
Blood Purif. 2008;26(1):23-9. doi: 10.1159/000110559. Epub 2008 Jan 10.
5
The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.脂肪因子作为心血管功能介质的新作用:生理学和临床视角。
Trends Cardiovasc Med. 2007 Nov;17(8):275-83. doi: 10.1016/j.tcm.2007.09.005.
6
The emerging biology of adipose tissue in chronic kidney disease: from fat to facts.慢性肾脏病中脂肪组织的新兴生物学:从脂肪到事实
Nephrol Dial Transplant. 2008 Oct;23(10):3041-6. doi: 10.1093/ndt/gfn376. Epub 2008 Jul 16.
7
Role of fat mass and adipokines in chronic kidney disease.脂肪量和脂肪因子在慢性肾脏病中的作用。
Curr Opin Nephrol Hypertens. 2008 Jan;17(1):25-31. doi: 10.1097/MNH.0b013e3282f2905f.
8
Adipokines in diabetes and cardiovascular diseases.糖尿病和心血管疾病中的脂肪因子。
Minerva Endocrinol. 2007 Sep;32(3):161-71.
9
Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.肥胖相关性高血压:瘦素在肾脏和心血管失稳态中的新作用。
Curr Opin Nephrol Hypertens. 2010 Jan;19(1):72-8. doi: 10.1097/MNH.0b013e328332fb49.
10
Insulin resistance in chronic uremia.慢性尿毒症中的胰岛素抵抗
J Ren Nutr. 2009 Jan;19(1):20-4. doi: 10.1053/j.jrn.2008.11.014.

引用本文的文献

1
Analyzing the association of estimated pulse wave velocity with the risk and mortality of chronic kidney disease: a study based on the NHANES database.分析估计脉搏波速度与慢性肾脏病风险及死亡率的关联:一项基于美国国家健康与营养检查调查(NHANES)数据库的研究
Int Urol Nephrol. 2025 Jul 14. doi: 10.1007/s11255-025-04660-6.
2
Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis.在接受血液透析的患者中验证食欲评估工具
J Ren Nutr. 2016 Mar;26(2):103-10. doi: 10.1053/j.jrn.2015.09.002. Epub 2015 Oct 28.
3
Visceral adipose tissue is associated with insulin resistance in hemodialyzed patients.
内脏脂肪组织与血液透析患者的胰岛素抵抗有关。
Med Sci Monit. 2015 Feb 20;21:557-62. doi: 10.12659/MSM.892078.
4
Association of serum vaspin and adiponectin levels with renal function in patients with or without type 2 diabetes mellitus.2型糖尿病患者与非2型糖尿病患者血清内脏脂肪素和脂联素水平与肾功能的关系
J Diabetes Res. 2014;2014:868732. doi: 10.1155/2014/868732. Epub 2014 Jul 15.
5
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients.体重指数对血液透析患者体重变化与死亡率相关性的影响。
Clin J Am Soc Nephrol. 2013 Oct;8(10):1725-33. doi: 10.2215/CJN.10951012. Epub 2013 Sep 5.
6
The serum vaspin levels are reduced in Japanese chronic hemodialysis patients.日本慢性血液透析患者血清中的 vaspin 水平降低。
BMC Nephrol. 2012 Dec 3;13:163. doi: 10.1186/1471-2369-13-163.
7
Relation between serum estradiol levels and mortality in postmenopausal female hemodialysis patients.绝经后女性血液透析患者血清雌二醇水平与死亡率的关系。
Int Urol Nephrol. 2013 Apr;45(2):503-10. doi: 10.1007/s11255-012-0171-7. Epub 2012 Apr 18.
8
Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease.终末期肾病患者炎症标志物 pentraxin-3 与体脂质量和腹型肥胖呈负相关。
Clin J Am Soc Nephrol. 2011 Dec;6(12):2785-91. doi: 10.2215/CJN.02320311.
9
Protein-energy wasting and mortality in chronic kidney disease.蛋白质-能量消耗与慢性肾脏病患者的死亡率。
Int J Environ Res Public Health. 2011 May;8(5):1631-54. doi: 10.3390/ijerph8051631. Epub 2011 May 19.
10
Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging?男性血液透析患者内源性睾酮与死亡率:这是衰老的结果吗?
Clin J Am Soc Nephrol. 2010 Nov;5(11):2018-23. doi: 10.2215/CJN.03600410. Epub 2010 Jul 22.